JPRN-UMIN000047903招募中未知
Translational research of "A multicenter Phase II basket study of Brigatinib in patients with ALK fusion gene-positive advanced/recurrent solid tumors" - WJOG15221MTR
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Others,meta-analysis etc
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
TiFFANY TRsolid malignanciesJPRN-jRCT1080224720ational Cancer Center Hospital East26
尚未招募
4 期
A multicenter, prospective, real-world study on the treatment of stable chronic obstructive pulmonary disease with Guben Kechuan granuleschronic obstructive pulmonary diseaseITMCTR2024000226Shanghai University of Traditional Chinese Medicine Affiliated Shuguang Hospital
已完成
不适用
TR accompanied with the study titled A multicenter phase II study of Nivolumab monotherapy in recurrent and/or metastatic gastrointestinal cancer patients with high Tumor Mutation Burden (TMB-H).Colorectal cancer, Gastric cancer, Esophageal cancer, Biliary tract cancer, Pancreatic cancer, and Other Solid cancerJPRN-UMIN000033560ational Cancer Center Hospital East70
招募中
不适用
Development of a non-interventional, multicenter registry for immune-mediated neuropathies with a study-specific biobank (Immunemediated Neuropathies Biomaterial and Data Register - INHIBIT-Register)G61.8G61.0Other inflammatory polyneuropathiesGuillain-Barré syndromeDRKS00024494Ruhr-Universität Bochum St. Josef-Hospital Klinik für Neurologie1,000
进行中（未招募）
不适用
A multicentre phase I-II study to investigate the combination of bendamustine with weekly paclitaxel as first or second line therapy in patients with metastatic breast cancer - RitaA multi-centre phase I-II study to investigate the combination of bendamustine with weekly paclitaxel as first or second line therapy in patients with metastatic breast cancerMedDRA version: 13.1Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2004-004880-31-DEGerman Breast Group Forschungs GmbH60